Dani Blum

I'm Dani Blum, a journalist at The New York Times.

I spend a lot of my time reporting on GLP-1 medications.

People call them weight loss drugs.

They are doing so much more in the body, and there's a lot of hope pinned on them.

I am spending part of truly every single workday making sure that I am up to date on the latest science.

I really want to make sure that I am talking to the leading researchers, keeping an eye on trial results,

and that I'm talking to people who are on these medications to learn more from them, to translate the really messy and murky and shifting science into a way that people can understand.

It's really important to have evidence-based answers to some of the questions that people have, especially about something as vital as a medication they're taking.

That's what you get when you subscribe to The New York Times.

If you already subscribe, thanks.

If you'd like to, go to mytimes.com slash subscribe.

New York Times game subscribers get full access to all our games and features.

Subscribe now at nytimes.com slash games for a special offer.